Chad A. Ellis - Concepedia

Author

Chad A. Ellis

National Institutes of Health

Also Known As

C. Ellis, Chad A Ellis, Chad A. Ellis, Chad A. Ellis (7989332), Chad Ellis, Elam, Candice

Publications

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health Center for Cancer Research National Cancer Institute Illinois College University of Illinois Urbana-Champaign

About

Chad A. Ellis is an author at National Institutes of Health specializing in cell biology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	90
2	Cell Biology	3	3	90
3	Natural Sciences	1	1	20
4	Biochemistry	1	1	20
5	Immunology	1	1	26

Chad A. Ellis

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis Michele D. Vos, Chad A. Ellis, Aaron Bell, Journal of Biological Chemistry	2000	295
Ca<sup>2+</sup> signalling and PKCα activate increased endothelial permeability by disassembly of VE—cadherin junctions Raudel Sandoval, Asrar B. Malik, Richard D. Minshall, The Journal of Physiology	2001	220
RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor Michele D. Vos, Chad A. Ellis, Candice Elam, Journal of Biological Chemistry	2003	183
Thrombin Induces Proteinase-activated Receptor-1 Gene Expression in Endothelial Cells via Activation of Gi-linked Ras/Mitogen-activated Protein Kinase Pathway Chad A. Ellis, Asrar B. Malik, Annette Gilchrist, Journal of Biological Chemistry	1999	131
The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung Michele D. Vos, Alfredo Martı́nez, Chad A. Ellis, Journal of Biological Chemistry	2003	122
Rig is a novel Ras-related protein and potential neural tumor suppressor Chad A. Ellis, Michele D. Vos, Heather Howell, Proceedings of the National Academy of Sciences	2002	67
Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression Chad A. Ellis, Chinnaswamy Tiruppathì, Raudel Sandoval, American Journal of Physiology-Cell Physiology	1999	53
RRP22 Is a Farnesylated, Nucleolar, Ras-Related Protein with Tumor Suppressor Potential Candice Elam, Luke B. Hesson, Michele D. Vos, Cancer Research	2005	42
A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells H. Christian Weber, James W. Walters, Julius Leyton, European Journal of Pharmacology Signal TransductionOncogenic AgentMedicineReceptor Tyrosine KinaseMek-1 Dependent Manner	2001	33
Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines Chad A. Ellis, Michele D. Vos, Meredith Wickline, Breast Cancer Research and Treatment Breast OncologyMedicineHormonal ReceptorInhibit GrowthCancer Growth	2003	31

Page 1